StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Wednesday. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of Ampio Pharmaceuticals stock opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The firm’s 50-day moving average is $0.03 and its two-hundred day moving average is $0.49. The stock has a market cap of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 2.21.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- What is a Secondary Public Offering? What Investors Need to Know
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- Election Stocks: How Elections Affect the Stock Market
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
